Benzinga | Aug 12, 2020 07:04AM EDT

DarioHealth Q2 EPS $(0.68) Beats $(1.40) Estimate, Adj. Net Loss $3.25M vs Loss $4.26M In Same Qtr. Last Year, Sales $1.79M Beat $1.55M Estimate

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(1.40) by 51.43 percent. This is a 423.08 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $1.79 million which beat the analyst consensus estimate of $1.55 million by 15.48 percent. This is a 8.42 percent increase over sales of $1.65 million the same period last year.